Guanhao Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	160.6	106.78	105.14	126.28	159.31
Cash & Short-Term Investments	160.6	106.78	105.14	126.28	159.31
Cash Growth	50.41%	1.56%	-16.74%	-20.73%	1.99%
Accounts Receivable	52.45	59.55	61.14	71.98	106.71
Other Receivables	2.96	2.21	13.36	8.74	11.04
Receivables	55.42	61.75	74.51	80.72	117.75
Inventory	77.71	78.46	71.6	61.68	140.55
Prepaid Expenses	0.43	-	-	-	-
Other Current Assets	31.45	18.8	16.03	30.22	17.81
Total Current Assets	325.61	265.79	267.28	298.89	435.41
Property, Plant & Equipment	332.47	332.47	252.04	214.6	245.54
Long-Term Investments	15.19	22.49	32.08	32.56	74.22
Goodwill	-	-	-	-	214.33
Other Intangible Assets	71.81	72.7	78.66	87.49	64.14
Long-Term Deferred Tax Assets	17.66	18.42	14.97	13.16	41.44
Long-Term Deferred Charges	33.87	29.88	24.17	23.58	23.66
Other Long-Term Assets	9.92	12.65	9.41	-	-
Total Assets	806.53	754.4	678.59	670.27	1,099
Accounts Payable	20.13	35.65	29.32	2.16	1.88
Accrued Expenses	65.05	59.45	58.01	52.96	83
Short-Term Debt	15	20.01	24.52	49.05	51.56
Current Portion of Long-Term Debt	2.22	0.09	-	-	54.69
Current Portion of Leases	3.96	5.64	6.07	7.49	9.51
Current Income Taxes Payable	3.4	4.71	3.96	13.72	14.62
Current Unearned Revenue	31.71	28.76	21.97	28.29	17.1
Other Current Liabilities	47.06	23.69	28.86	35.32	29.91
Total Current Liabilities	188.54	177.99	172.72	188.99	262.27
Long-Term Debt	103.89	76	12.02	-	-
Long-Term Leases	1.85	6.62	12.06	22.52	35.62
Long-Term Unearned Revenue	18.21	19.43	20.65	22.85	40.94
Long-Term Deferred Tax Liabilities	5.42	6.77	4.9	4.97	11.74
Other Long-Term Liabilities	0.8	-	-	-	-
Total Liabilities	318.72	286.81	222.33	239.33	350.58
Common Stock	265.16	265.16	265.16	265.16	265.16
Additional Paid-In Capital	598.03	594.54	600.27	600.27	597.71
Retained Earnings	-246.6	-270.95	-298.37	-329.37	-21.57
Comprehensive Income & Other	-46.51	-46.39	-46.46	-50.71	-57.38
Total Common Equity	570.07	542.36	520.59	485.34	783.92
Minority Interest	-82.25	-74.77	-64.33	-54.4	-35.76
Shareholders' Equity	487.82	467.59	456.26	430.94	748.16
Total Liabilities & Equity	806.53	754.4	678.59	670.27	1,099
Total Debt	126.93	108.35	54.67	79.06	151.38
Net Cash (Debt)	33.68	-1.57	50.47	47.22	7.93
Net Cash Growth	-	-	6.88%	495.52%	-
Net Cash Per Share	0.12	-0.01	0.20	0.18	0.03
Filing Date Shares Outstanding	265.16	265.16	265.16	265.16	265.16
Total Common Shares Outstanding	265.16	265.16	265.16	265.16	265.16
Working Capital	137.07	87.8	94.56	109.9	173.14
Book Value Per Share	2.15	2.05	1.96	1.83	2.96
Tangible Book Value	498.25	469.66	441.93	397.85	505.45
Tangible Book Value Per Share	1.88	1.77	1.67	1.50	1.91
Buildings	392.94	392.83	225.53	239.59	239.59
Machinery	99.79	99.41	99.17	101.29	106.02
Construction In Progress	18.03	2.54	73.99	2.8	2.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.